IRIS Accounts Production v24.3.2.46 10492102 Board of Directors 1.12.23 30.11.24 30.11.24 0 0 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104921022023-11-30104921022024-11-30104921022023-12-012024-11-30104921022022-11-30104921022022-12-012023-11-30104921022023-11-3010492102ns15:EnglandWales2023-12-012024-11-3010492102ns14:PoundSterling2023-12-012024-11-3010492102ns10:Director12023-12-012024-11-3010492102ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3010492102ns10:SmallEntities2023-12-012024-11-3010492102ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3010492102ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3010492102ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3010492102ns10:AbridgedAccounts2023-12-012024-11-3010492102ns10:Director22023-12-012024-11-3010492102ns10:Director32023-12-012024-11-3010492102ns10:RegisteredOffice2023-12-012024-11-3010492102ns5:CurrentFinancialInstruments2024-11-3010492102ns5:CurrentFinancialInstruments2023-11-3010492102ns5:Non-currentFinancialInstruments2024-11-3010492102ns5:Non-currentFinancialInstruments2023-11-3010492102ns5:ShareCapital2024-11-3010492102ns5:ShareCapital2023-11-3010492102ns5:RetainedEarningsAccumulatedLosses2024-11-3010492102ns5:RetainedEarningsAccumulatedLosses2023-11-3010492102ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-11-3010492102ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-11-3010492102ns5:Secured2024-11-3010492102ns5:Secured2023-11-3010492102ns5:KeyManagementIndividualGroup12023-12-012024-11-30
REGISTERED NUMBER: 10492102 (England and Wales)










Unaudited Financial Statements

for the Year Ended 30 November 2024

for

DNA Developments (York) Limited

DNA Developments (York) Limited (Registered number: 10492102)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


DNA Developments (York) Limited

Company Information
for the Year Ended 30 November 2024







DIRECTORS: A Sykes
N Speakman
D S Rhodes





REGISTERED OFFICE: 121 Almsford Road
York
North Yorkshire
YO26 5NU





REGISTERED NUMBER: 10492102 (England and Wales)





ACCOUNTANTS: Hallgarth Accountants Ltd
2 Hallgarth
Pickering
North Yorkshire
YO18 7AW

DNA Developments (York) Limited (Registered number: 10492102)

Abridged Balance Sheet
30 November 2024

30.11.24 30.11.23
Notes £    £    £    £   
FIXED ASSETS
Investment property 4 1,625,000 1,747,500

CURRENT ASSETS
Stocks - 262,110
Debtors 133,079 144,884
Cash at bank 12,684 7,376
145,763 414,370
CREDITORS
Amounts falling due within one year 1,010,144 1,218,188
NET CURRENT LIABILITIES (864,381 ) (803,818 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

760,619

943,682

CREDITORS
Amounts falling due after more than one
year

5

(367,550

)

(367,550

)

PROVISIONS FOR LIABILITIES (70,466 ) (93,741 )
NET ASSETS 322,603 482,391

CAPITAL AND RESERVES
Called up share capital 12 12
Retained earnings 322,591 482,379
322,603 482,391

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DNA Developments (York) Limited (Registered number: 10492102)

Abridged Balance Sheet - continued
30 November 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 30 November 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 March 2025 and were signed on its behalf by:





A Sykes - Director


DNA Developments (York) Limited (Registered number: 10492102)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

DNA Developments (York) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

DNA Developments (York) Limited (Registered number: 10492102)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

4. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 December 2023 1,747,500
Revaluations (122,500 )
At 30 November 2024 1,625,000
NET BOOK VALUE
At 30 November 2024 1,625,000
At 30 November 2023 1,747,500

Included in fair value of investment property is freehold land of £ 1,625,000 (2023 - £ 1,747,500 ) which is not depreciated.

The investment property portfolio has been duly valued by professional bodies appointed by the directors.

The valuation for 105 Millfield Lane was undertaken on the 26th August 2020 and valued at £525,000.

The valuation for 3 Bishopthorpe Road was undertaken on the 15th November 2021 and valued at £950,000.

As at the 30th November 2024, the directors reviewed the valuations above as well as the revaluations of each property and deem that the Investment Property disclosed gives a true and fair representation of the properties held.

Fair value at 30 November 2024 is represented by:
£   
Valuation in 2020 1,334,461
Valuation in 2021 140,868
Valuation in 2022 272,171
Valuation in 2024 (122,500 )
1,625,000

5. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE
YEARS
30.11.24 30.11.23
£    £   
Repayable otherwise than by instalments
Bank loans more 5 yrs non-inst 367,550 367,550

DNA Developments (York) Limited (Registered number: 10492102)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

6. SECURED DEBTS

The following secured debts are included within creditors:

30.11.24 30.11.23
£    £   
JD Cummins & FEJ Cummins - 50,000
SM Jagger 689,500 620,550
689,500 670,550

A legal charge was issued on the 28 October 2020 over the property known as 3 Bishopthorpe Road, York to the value of £485,000, in relation to a loan from S M Jagger. A further charge was secured on the 1st December 2021 for £204,500.

7. RELATED PARTY DISCLOSURES

DNA Developments (York) Limited received an interest free loan from Intotal Developments Limited during the 2021 reporting period. The balance owed at the year end was £126,300 (2023: £141,300) which is repayable on demand.

A further loan was made to Bish Two York Limited to the value of £4,500 which left a balance outstanding of £6,500 (2023: £2,000) which is interest free and repayable on demand.

During an earlier reporting period, Bish Road York Limited made a loan to the company. This loan was repaid in full during this reporting period (2023: £1,500) and was interest free and repayable on demand. During the year, the company made a loan to Bish Road York Limited to the value of £17,000. This was outstanding at the year end. The loan is interest free and repayable on demand.

Intotal Developments Limited, Bish Two York Limited and Bish Road York Limited are companies with the same controlling parties.